How long can the American customer love myth of high growth last? | Insight Research

Despite 3 consecutive years of high performance growth, market concerns about Aimeike's future growth momentum have not been resolved.

wallstreetcnMar 19 23:37 ET

Behind the slowdown in Aimeike's growth rate in the 3rd quarter: “Women's Maotai” can't handle the slump in consumption?

Demand weakens

wallstreetcnOct 25, 2023 03:55 ET

Medical beauty earns 200 million dollars a month and has to participate in the internal volume of diet pills. Where is the boundary of America's ambition?

It's not easy to take diet pills

wallstreetcnAug 24, 2023 13:11 ET

Aoyuan Healthy Life Arm Offloading 30% Stake in Health Services JV

MT NewswiresOct 19, 2021 02:43 ET

Analysis of the limit of Olympian Meigu on September 24: healthy China, Medical Beauty and Old-age Industry concept Hot stocks

Securities Star data Center News, Aoyuan Mei Valley rose to close, closing price 14.25 yuan. The stock rose by the limit at 11:21 and opened the limit once. The closing capital was 36.8975 million yuan, accounting for 0.34% of its current market value. In terms of capital flow data, the net inflow of main funds on the same day was 195 million yuan, the net inflow of hot capital was 205 million yuan, and the net outflow of retail funds was 96.5732 million yuan. In the past 5 days, the capital flow is shown in the following table: this stock is a hot stock of healthy China, medical beauty and pension industry concept. On the same day, healthy China concept rose 1.4% and medical beauty concept rose 1.25%. The stock investment

證券之星Sep 24, 2021 03:11 ET

Read Huaxi Biology 2021 China News in one picture

According to the Securities Star data Center, Huaxi Biological 2021 reported that the company's main income was 1.937 billion yuan, up 104.44% from the same period last year; the net profit from its parent was 361 million yuan, up 35.01% from the same period last year; deducting 306 million yuan from non-net profit, up 30.68% from the same period last year; debt ratio 20.03%, investment income 21.2031 million yuan, financial expenses 4.0533 million yuan, gross profit margin 77.91%. There are three new shareholders in this period, J.P. MorganSecuritiesPLC-804211 shares held by its own funds, accounting for the proportion of outstanding shares.

證券之星Sep 21, 2021 09:24 ET